World's Best Scientists 2026 revealed!
Detlef Zillikens

Detlef Zillikens

D-Index & Metrics

Immunology

D-Index
102
Citations
35996
World Ranking
680
National Ranking
40

Medicine

D-Index
102
Citations
36627
World Ranking
7694
National Ranking
437

Overview

Detlef Zillikens was affiliated with the University of Lübeck in Germany and contributed extensively to research in the field of medicine, focusing notably on autoimmune bullous skin diseases and related dermatological conditions. Their work spanned over 361 publications in medicine, with notable specialization in pathology and forensic medicine, rheumatology, genetics, dermatology, and epidemiology.

The scientist's research covered significant topics including:

  • Autoimmune Bullous Skin Diseases
  • Urticaria and Related Conditions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Dermatology and Skin Diseases
  • Platelet Disorders and Treatments
  • Nail Diseases and Treatments
  • Cancer Immunotherapy and Biomarkers

Zillikens contributed to various high-impact publication venues, often publishing in journals such as:

  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the European Academy of Dermatology and Venereology
  • Frontiers in Immunology
  • Journal of Investigative Dermatology
  • Frontiers in Medicine

Their collaborative work involved frequent co-authorships with researchers including Enno Schmidt, Ralf J. Ludwig, Christian D. Sadik, Katharina Boch, and Christoph M. Hammers.

Major papers authored or co-authored by Zillikens include:

  • "Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)", 2020, Journal of the European Academy of Dermatology and Venereology
  • "UpdatedS2K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)", 2022, Journal of the European Academy of Dermatology and Venereology
  • "European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II", 2021, Journal of the European Academy of Dermatology and Venereology
  • "Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases", 2022, Frontiers in Medicine
  • "European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I", 2021, Journal of the European Academy of Dermatology and Venereology

Best Publications

  • The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.

    Lawrence S. Chan;A. Razzaque Ahmed;Grant J. Anhalt;Wolfgang Bernauer

  • S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update

    Enno Schmidt;Michael Sticherling;Miklós Sárdy;Rüdiger Eming

  • Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

    Dedee F. Murrell;Sarah Dick;A. R. Ahmed;Masayuki Amagai

  • Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

    Christian M. Karsten;Manoj K. Pandey;Julia Figge;Regina Kilchenstein

  • The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile

    Masayuki Amagai;Kazuyuki Tsunoda;Detlef Zillikens;Tetsuo Nagai

  • Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

    Enno Schmidt;Karin Obe;Eva-Bettina Bröcker;Detlef Zillikens

  • Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

    Dedee F. Murrell;Benjamin S. Daniel;Pascal Joly;Luca Borradori

  • Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) in ex vivo human skin.

    Tobias W. Fischer;Konrad Kleszczyński;Lena H. Hardkop;Nathalie Kruse

  • Diagnosis and management of pemphigus: Recommendations of an international panel of experts

    Dedee F. Murrell;Sandra Peña;Sandra Peña;Pascal Joly;Branka Marinovic

  • Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies

    Detlef Zillikens;Pamela A. Rose;Shawn D. Balding;Zhi Liu

  • Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

    Franziska Bertram;Eva‐B. Bröcker;Detlef Zillikens;Detlef Zillikens;Enno Schmidt;Enno Schmidt

  • Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

    Claudio Feliciani;P. Joly;M. F. Jonkman;G. Zambruno

  • Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

    M Hertl;H Jedlickova;S Karpati;B Marinovic

  • A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus

    Stefan Beissert;Thomas Werfel;Uta Frieling;Markus Böhm

  • Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

    P. Joly;B. Horvath;Α Patsatsi;S. Uzun

  • Incidence of Autoimmune Subepidermal Blistering Dermatoses in a Region of Central Germany

    Detlef Zillikens;Sabine Wever;Alexa Roth;Beate Weidenthaler-Barth

  • Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen

    Cassian Sitaru;Sidonia Mihai;Christoph Otto;Mircea T. Chiriac

  • A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone

    Detlef Zillikens;Detlef Zillikens;Yoshie Kawahara;Akira Ishiko;Hiroshi Shimizu

  • A Highly Sensitive Enzyme-Linked Immunosorbent Assay for the Detection of Circulating Anti-BP180 Autoantibodies in Patients with Bullous Pemphigoid

    Detlef Zillikens;Jose M. Mascaro;Pamela A. Rose;Zhi Liu

  • Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

    Berthold Rzany;Karin Partscht;Martin Jung;Werner Kippes

  • The Shed Ectodomain of Collagen XVII/BP180 Is Targeted by Autoantibodies in Different Blistering Skin Diseases

    Hauke Schumann;Jens Baetge;Kaisa Tasanen;Kaisa Tasanen;Fenella Wojnarowska

  • Anti-laminin gamma-1 pemphigoid

    Teruki Dainichi;Sadamu Kurono;Bungo Ohyama;Norito Ishii

  • Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.

    Christian Probst;Wolfgang Schlumberger;Winfried Stöcker;Andreas Recke

  • Anti‐p200 pemphigoid: A novel autoimmune subepidermal blistering disease

    Amrei Dilling;Christian Rose;Takashi Hashimoto;Detlef Zillikens

  • Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited.

    N. van Beek;A. Dohse;F. Riechert;V. Krull

Frequent Co-Authors

Enno Schmidt
Enno Schmidt University of Lübeck
Ralf Ludwig
Ralf Ludwig University of Rostock
Cassian Sitaru
Cassian Sitaru University of Freiburg
Eva-B. Bröcker
Eva-B. Bröcker University of Würzburg
Takashi Hashimoto
Takashi Hashimoto Osaka Metropolitan University
Marcel F. Jonkman
Marcel F. Jonkman University Medical Center Groningen
Matthias Goebeler
Matthias Goebeler University of Würzburg
Jörg Köhl
Jörg Köhl University of Lübeck
Luis A. Diaz
Luis A. Diaz Memorial Sloan Kettering Cancer Center
Masayuki Amagai
Masayuki Amagai Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, related healthcare pathways can offer rewarding career opportunities. Many students choose to enhance their understanding by pursuing nursing degrees that complement immunology knowledge, providing hands-on clinical skills in patient care and disease management.

If you’re looking for programs that balance quality with accessibility, exploring the easiest accelerated nursing programs to get into is a great start. These programs allow students to earn a Bachelor of Science in Nursing (BSN) faster and with fewer barriers.

For those aiming to begin their nursing career quickly, accredited LPN programs can be a practical first step. Check out accredited lpn programs easy to get into for options that provide foundational nursing education and credentials.

Advancing beyond initial nursing roles, many consider specialized degrees. The easiest nurse practitioner program options can help students achieve advanced practice status with less demanding admissions criteria, opening doors to higher responsibility and autonomy.

Specializing in mental health nursing is also a strong career path. The top psychiatric mental health nurse practitioner programs online offer convenient, reputable programs with excellent clinical placement opportunities for those focusing on psychiatric care within immunology-related fields.

Best Scientists Citing Detlef Zillikens